Aion Therapeutic Inc. (OTCPK: ANTC.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Aion Therapeutic Inc. (OTCPK: ANTC.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $994.30K.
trading between 0.00 and 0.02.
Tweenvest scores Aion Therapeutic Inc. across four factors: quality 8/100. Its strongest factor is quality.
ANTC.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $994.30K
- Revenue (TTM)
- $1.02M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 4.71
- 52-week high
- $0.02
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 497.15M
- Employees
- —
- Next earnings
- —
About Aion Therapeutic Inc.
Headquartered in Toronto, Canada, Aion Therapeutic Inc. provides medical cannabis products across the nation. The company, which was established in 2011, formerly operated as Osoyoos Cannabis Inc. until it officially adopted its current name in August 2020.
- ISIN
- CA00905T1021
- Founded
- 2011
- Listed since
- Feb 21, 2019
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.